SpayVac for Wildlife
SpayVac develops no-booster fertility-control vaccines proven in wildlife, production animals, aquaculture, and companion animals. Their technology is based on a patented liposome platform that creates long-lasting, targeted immune responses to render animals infertile with a single dose. The company focuses on innovative solutions for animal population management across various species, including wildlife, farm animals, and pets, aiming to provide effective, economical, and sustainable fertility control options.
Industries
Nr. of Employees
small (1-50)
SpayVac for Wildlife
1202 Ann Street, Madison, Wisconsin 53713, United States
Products
Single-dose fertility-control vaccine (liposome-encapsulated antigen)
A single-injection contraceptive vaccine formulation that uses liposome encapsulation to present protein antigens (e.g., pZP or GnRH) and induce multi-year antibody-mediated infertility or delayed sexual maturation in target species.
Single-dose fertility-control vaccine (liposome-encapsulated antigen)
A single-injection contraceptive vaccine formulation that uses liposome encapsulation to present protein antigens (e.g., pZP or GnRH) and induce multi-year antibody-mediated infertility or delayed sexual maturation in target species.
Services
Design and run species-specific efficacy and dose-optimization trials in partnership with academic, conservation, and industry collaborators.
In-house production and supply of vaccine batches from a research and production laboratory, with capability for international shipment.
Development of laboratory testing methods and batch release specifications for vaccine quality control.
Design and run species-specific efficacy and dose-optimization trials in partnership with academic, conservation, and industry collaborators.
In-house production and supply of vaccine batches from a research and production laboratory, with capability for international shipment.
Development of laboratory testing methods and batch release specifications for vaccine quality control.
Expertise Areas
- Immunocontraceptive vaccine development
- Field trial design and execution for wildlife and aquaculture species
- Vaccine formulation and liposome delivery
- Scale-up biomanufacturing for biologics
Key Technologies
- Liposome vaccine delivery
- Porcine zona pellucida (pZP) antigen immunization
- GnRH antigen immunization
- Single-injection, long-duration vaccine formulations
News & Updates
Expansion of licensing agreement to include aquaculture, building on successful trials in farm-raised salmon and trout.
Shipment of vaccines to Europe from Madison laboratory, marking a milestone in global distribution.
Discussion with CEO Tom D'Orazio about the company's progress and opportunities.
Facility now operational for vaccine production.
Trial in Thailand to evaluate contraceptive efficacy in Asian elephants.
Partnership with aquaculture leader to test single-injection vaccines in farmed rainbow trout.
Expansion of licensing agreement to include aquaculture, building on successful trials in farm-raised salmon and trout.
Shipment of vaccines to Europe from Madison laboratory, marking a milestone in global distribution.
Discussion with CEO Tom D'Orazio about the company's progress and opportunities.
Facility now operational for vaccine production.
Trial in Thailand to evaluate contraceptive efficacy in Asian elephants.
Partnership with aquaculture leader to test single-injection vaccines in farmed rainbow trout.